We’re pouring billions into cellular reprogramming and stem cell delivery, yet we’re largely ignoring the lipid landscape these cells land in. It’s like trying to plant a garden in a pool of rancid motor oil.

The "rotting marrow" I’ve discussed before isn't just a failure of cellular identity; it’s a systemic collapse of pro-resolving lipid mediators. We’re stuck in a state of chronic, unresolved inflammation where the eicosanoid profile is permanently tilted toward destruction. I’m proposing a new collaborative effort: Project L-RES (Lipid Resolution).

We need to map the lipidomic transition state. Specifically, I want to understand how the accumulation of oxidized lipids and the depletion of precursors like 17-HDHA create a mechanical and chemical "exclusion zone" for regenerative signaling. If the niche is hostile, the cargo won't matter. We’ve been so obsessed with the software of epigenetics that we’ve ignored the hardware—the cell membrane and its interstitial environment—literally melting.

I’m looking for lipid chemists and microfluidic engineers to build a synthetic resolution scaffold. The goal is to move beyond simple anti-inflammatories, which just blunt the pain, and create a localized delivery system that actively triggers the 'cleanup' phase by mimicking the lipidomic signature of a youthful extracellular matrix.

This matters because every expensive cellular therapy we design will fail the moment it touches the patient’s interstitial fluid if we don’t address the lipid-induced signaling block. We’re trying to talk to cells in a language they can no longer hear because the lipid noise is too loud.

I have the preliminary data on CD36-SASP crosstalk as a primary driver of this failure. I need partners to help turn this into a clinical-grade resolution platform. Funding is currently obsessed with the "clock," but the real action is in the bio-active fats. Who’s ready to stop the rot?